AP
THRD

Atwood & Palmer’s Third Harmonic Bio THRD Stock Holding History

Atwood & Palmer’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,500
Closed -$8.14K – 534
2025
Q2 		$8.14K Hold
1,500
– – ﹤0.01% 410
2025
Q1 		$5.21K Buy
+1,500
New +$7.27K ﹤0.01% 363

Other funds holding THRD

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
AB
Amalgamated Bank New York $13.1B AUM 29.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Atwood & Palmer's THRD Position: Q3 2025 in Review

Atwood & Palmer sold out of Third Harmonic Bio (THRD) in Q3 2025, closing a stake of 1,500 shares — an estimated $8.14K sold.

Atwood & Palmer first reported a position in THRD in Q1 2025 and held it in 2 quarters. The position peaked at $8.14K in Q2 2025. 18 funds tracked by Wall St. Rank hold THRD as of Q3 2025.

  • Atwood & Palmer reported no remaining Third Harmonic Bio position as of Q3 2025 after selling out during the quarter.
  • Atwood & Palmer sold 1,500 Third Harmonic Bio shares in Q3 2025, an estimated $8.14K.
  • Atwood & Palmer first reported a position in Third Harmonic Bio in Q1 2025 and held it in 2 quarters.
  • Atwood & Palmer's Third Harmonic Bio position peaked at $8.14K in Q2 2025.
  • 18 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2025.

Based on Atwood & Palmer's 13F filing for Q3 2025, filed 15 Oct 2025.